These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6673832)
1. Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrel. Gore RD Clin Ther; 1983; 6(1):86-93. PubMed ID: 6673832 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of hypertension with propranolol in combination with other antihypertensive agents]. Dück KD Z Gesamte Inn Med; 1975 Nov; 30(22):727-30. PubMed ID: 1210474 [TBL] [Abstract][Full Text] [Related]
3. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
4. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension. Levine B Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450 [TBL] [Abstract][Full Text] [Related]
5. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]. Schühlen H; Abts M; Kastrati D Herz; 2007 Aug; 32(5):419-25. PubMed ID: 17687532 [TBL] [Abstract][Full Text] [Related]
6. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease. Abe M; Okada K; Maruyama T; Matsumoto K Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011 [TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive efficacy of monotherapy in increasing doses versus therapy associated in low doses]. Fasce E; Wagemann H Rev Med Chil; 1999 Aug; 127(8):911-8. PubMed ID: 10752251 [TBL] [Abstract][Full Text] [Related]
8. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components. MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension. Saruta T; Ogihara T; Matsuoka H; Suzuki H; Toki M; Hirayama Y; Nonaka K; Takahashi K Hypertens Res; 2007 Aug; 30(8):729-39. PubMed ID: 17917321 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension. Sachse A; Verboom CN; Jäger B J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506 [TBL] [Abstract][Full Text] [Related]
11. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872 [TBL] [Abstract][Full Text] [Related]
13. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052 [TBL] [Abstract][Full Text] [Related]
14. [Comparison on antihypertensive and cardiac effects of guanadrel and propranolol]. Jiao PH; Allen JW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Feb; 7(1):67-8. PubMed ID: 3158422 [No Abstract] [Full Text] [Related]
15. Comparison of guanadrel and guanethidine efficacy and side effects. Malinow SH Clin Ther; 1983; 5(3):284-9. PubMed ID: 6850722 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. Rosei EA; Rizzoni D; J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes. Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R; J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension. Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of clinical and ambulatory measurements of blood pressure with benazepril alone or combined with hydrochlorothiazide in hypertension]. Le Feuvre C; Francillon A; Renucci JF; Cocco-Guyomarch L; Muller M; Peuplier P; Poggi L Therapie; 1996; 51(1):27-34. PubMed ID: 8762217 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients. de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]